Today, Opko Health Inc. (OPK) CEO Phillip Md Et Al Frost Acquires 1,800 Shares of Stock

Today, Opko Health Inc. (OPK) CEO Phillip Md Et Al Frost Acquires 1,800 Shares of Stock

Opko Health Inc. (NYSE:OPK) CEO Phillip Md Et Al Frost bought 1,800 shares of the firm’s stock in a transaction dated Friday, October 14th. The shares were acquired at an average price of $9.48 per share, with a total value of $17,064.00. Following the completion of the transaction, the chief executive officer now owns 3,068,951 shares of the company’s stock, valued at approximately $29,093,655.48. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Phillip Md Et Al Frost also recently made the following trade(s): On Thursday, October 13th, Phillip Md Et Al Frost bought 5,400 shares of Opko Health stock. The shares were acquired at an average price of $9.52 per share, with a total value of $51,408.00. On Tuesday, October 11th, Phillip Md Et Al Frost bought 7,200 shares of Opko Health stock. The shares were acquired at an average price of $9.78 per share, with a total value of $70,416.00. On Monday, October 10th, Phillip Md Et Al Frost acquired 24,800 shares of Opko Health stock. The stock was purchased at an average price of $9.82 per share, with a total value of $243,536.00. On Thursday, October 6th, Phillip Md Et Al Frost acquired 4,200 shares of Opko Health stock. The stock was purchased at an average price of $10.53 per share, with a total value of $44,226.00. On Tuesday, October 4th, Phillip Md Et Al Frost acquired 3,600 shares of Opko Health stock. The stock was purchased at an average price of $10.57 per share, with a total value of $38,052.00. On Friday, September 30th, Phillip Md Et Al Frost acquired 1,800 shares of Opko Health stock. The stock was purchased at an average price of $10.54 per share, with a total value of $18,972.00. On Thursday, September 29th, Phillip Md Et Al Frost acquired 3,600 shares of Opko Health stock. The stock was purchased at an average price of $10.67 per share, with a total value of $38,412.00. On Wednesday, September 28th, Phillip Md Et Al Frost acquired 5,400 shares of Opko Health stock. The stock was purchased at an average price of $11.01 per share, with a total value of $59,454.00. On Tuesday, September 27th, Phillip Md Et Al Frost acquired 1,800 shares of Opko Health stock. The stock was purchased at an average price of $11.16 per share, with a total value of $20,088.00. On Monday, September 26th, Phillip Md Et Al Frost acquired 1,800 shares of Opko Health stock. The stock was purchased at an average price of $11.04 per share, with a total value of $19,872.00.

Shares of Opko Health Inc. (NYSE:OPK) opened at 9.31 on Tuesday. The stock’s 50 day moving average price is $10.09 and its 200-day moving average price is $10.05. Opko Health Inc. has a 52 week low of $7.12 and a 52 week high of $11.85. The stock has a market cap of $5.12 billion and a price-to-earnings ratio of 38.95.

Opko Health (NYSE:OPK) last announced its earnings results on Monday, August 8th. The company reported $0.02 EPS for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.05. The firm had revenue of $357.10 million for the quarter, compared to analysts’ expectations of $324.11 million. During the same quarter last year, the business earned ($0.09) earnings per share. The business’s revenue was up 742.2% compared to the same quarter last year. Equities analysts anticipate that Opko Health Inc. will post ($0.05) earnings per share for the current fiscal year.

A number of institutional investors have recently made changes to their positions in OPK. Smith Graham & Co. Investment Advisors LP boosted its position in shares of Opko Health by 3.0% in the third quarter. Smith Graham & Co. Investment Advisors LP now owns 585,102 shares of the company’s stock worth $6,196,000 after buying an additional 16,930 shares during the period. Parametrica Management Ltd purchased a new position in shares of Opko Health during the third quarter worth approximately $287,000. Prospera Financial Services Inc purchased a new position in shares of Opko Health during the third quarter worth approximately $319,000. Capstone Asset Management Co. boosted its position in shares of Opko Health by 3.3% in the third quarter. Capstone Asset Management Co. now owns 16,216 shares of the company’s stock worth $172,000 after buying an additional 520 shares during the period. Finally, Creative Planning boosted its position in shares of Opko Health by 72.4% in the third quarter. Creative Planning now owns 169,124 shares of the company’s stock worth $1,791,000 after buying an additional 70,999 shares during the period.

OPK has been the subject of several recent research reports. Standpoint Research lifted their price objective on Opko Health from $16.00 to $18.00 and gave the company a “buy” rating in a report on Tuesday, June 21st. Oppenheimer Holdings Inc. reiterated an “outperform” rating on shares of Opko Health in a report on Saturday, June 25th. Zacks Investment Research downgraded shares of Opko Health from a “hold” rating to a “sell” rating in a report on Friday, July 1st. JPMorgan Chase & Co. set a $14.00 target price on shares of Opko Health and gave the stock a “buy” rating in a report on Tuesday, August 9th. Finally, Jefferies Group reiterated a “hold” rating on shares of Opko Health in a report on Wednesday, August 17th. Five investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $13.20.

Opko Health Company Profile

Related posts

Leave a Comment